logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
H

Hussain Abdulrahman Al‐Omar

clinical pharmacy

13H-index
75Paper Count
514Citation Count
Published Papers 29
Publication Date
logo
Mapping the landscape of managed entry agreements: a systematic review of global frameworks; system-level components; and implementation challenges
errFrontiers in Pharmacology
IF4.8
err2026-04-20
err0
errOAAI
errHA Hussain Abdulrahman Al-Omar †; AA Asma Abdulaziz Almuhsin †; LH Lolwa Hamad Almudaiyan †; AH Amal Hassan Al-Najjar †; LC Laila Carolina Abu Esba †; HA Hind Almodaimegh †; JA Jehan Alamre †; CC Consuela Cheriece Yousef †; MA Mansoor Ahmed Khan †; KA Khalid AlYahya †; ES Esraa S. Altawil †; AS Abdualmajeed Saad Binjumayah; FA Faisal Awwadh Alharbi; ST Sultan Tawfiq AlShurbaji †; FM Fatma Maraiki †; JE Jaime Espín †; RT Rosanna Tarricone †; PK Panos Kanavos †
errShare
errSave
Expert Delphi consensus on surrogate endpoints for treatment assessment in metabolic dysfunction-associated steatohepatitis
errClinical Gastroenterology and Hepatology
IF12
err2025-12-06
err0
PREAI
errArun J. Sanyal; Atsushi Nakajima; Elisabetta Bugianesi; Giada Sebastiani; Jörn M. Schattenberg; Leon A. Adams; Mazen Noureddin; Masato Yoneda; Pierre Bedossa; Zobair M. Younossi; Assim A. Alfadda; Andreas Geier; Frank Tacke; Giulio Marchesini; Giovanni Targher; Hussain Abdulrahman Al-Omar; Hannes Hagström; Juan G. Abraldes; Jerome Boursier; Kento Imajo
errShare
errSave
Navigating barriers to real-world evidence utilization for drug regulatory affairs and market access in Saudi Arabia
errFrontiers in Pharmacology
IF4.8
err2025-12-02
err0
errOAAI
errHatouf H. Sukkarieh†; Nourah Al Fayez†; Hussain Abdulrahman Al-Omar†; Nura O. Azmi; Bushra Syed; Raed A. Albar; Nawaf Al Bali
errShare
errSave
Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries
errLiver International
IF5.2
err2025-11-05
err0
errOAAI
errJeffrey V. Lazarus; Leire Agirre-Garrido; J. Emilio Miralles-Sanchez; Melina I. Manolas; Frank Tacke; Cristiane A. Villela-Nogueira; Hussain Abdulrahman Al-Omar; Saleh A. Alqahtani; Lamya Mohammed Yahya Alzubaidi; Meena Bansal; Kenneth Cusi; Scott D. Isaacs; Didac Mauricio; Teruki Miyake; Rodrigo O. Moreira; Shoko Nakazawa; Silvana Pannain; Juan M. Pericàs; Michael Roden; Hirokazu Takahashi; Nicolai Brachowicz
errShare
errSave
Featured Cover
errLiver International
IF5.2
err2025-10-30
err0
errOAAI
errJeffrey V. Lazarus; Leire Agirre-Garrido; J. Emilio Miralles-Sanchez; Melina I. Manolas; Frank Tacke; Cristiane A. Villela-Nogueira; Hussain Abdulrahman Al-Omar; Saleh A. Alqahtani; Lamya Mohammed Yahya Alzubaidi; Meena Bansal; Kenneth Cusi; Scott D. Isaacs; Didac Mauricio; Teruki Miyake; Rodrigo O. Moreira; Shoko Nakazawa; Silvana Pannain; Juan M. Pericàs; Michael Roden; Hirokazu Takahashi; Nicolai Brachowicz
errShare
errSave
Challenges in evaluation and reimbursement of drugs for rare diseases in Saudi Arabia: a Delphi expert consensus
errJournal of Pharmaceutical Policy and Practice
IF2.5
err2025-10-28
err0
errOAAI
errLaila Carolina Abu Esba; Consuela Cheriece Yousef; Mansoor Ahmed Khan; Sakra Balhareth; Hussain A. Al-Omar; Amal Al-Najjar; Aljawharah Alkoraishi; Abdullah M. Alhammad; Ziyad Saeed Almalki; Esraa S. Altawil; Roaa Al Gain; Mohamed Ahmed; Hend Metwali; Layla Al Anizy; Fatma Maraiki; Abdulrazaq Al Jazairi; Abdulaziz Alhossan; Mohammed Al Harbi; Hind Almodaimegh
errShare
errSave
Supplementary Material for Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data from Nine Countries
errClinical Gastroenterology and Hepatology
IF12
err2025-09-08
err0
PREAI
errZobair M. Younossi; James M. Paik; Jeffrey V. Lazarus; Patrizia Burra; Yuichiro Eguchi; Frank Tacke; Javier Crespo; Cristiane A. Villela-Nogueira; Paul N. Brennan; Hussain Abdulrahman Al-Omar; Manuel Romero-Gomez; Cyrielle Caussy; Mário Guimarães Pessoa; Kenneth Cusi; Michael Roden; Hirokazu Takahashi; Amalia Gastaldelli; Jörn M. Schattenberg; Claudia Pinto Oliveira; Takumi Kawaguchi; Yuko Eguchi; Jerome Boursier; Faisal Abaalkhail; Jeremy W. Tomlinson; Alina M. Allen; Vincent Wai-Sun Wong; Elisabetta Bugianesi; Philip N. Newsome; Jose Luis Calleja; Nicolai Brachowicz; Leire Agirre-Garrido; Douglas Maya-Miles; Habeeb I.A. Razack; Henry E. Mark; Ariana Nader; Sara Battistella; Jennifer Margier; Alessandra Risso; Maria Stepanova; Fatema Nader; Linda Henry; Laurent Castera; Saleh A. Alqahtani
errShare
errSave
Contextual factors in value-based decision support to enhance health technologies adoption: the case of biosimilars
errFrontiers in Pharmacology
IF4.8
err2025-08-13
err0
errOAAI
errMaximilian Otte; Zoltán Kaló; Hussain Abdulrahman Al-Omar†; Meindert Boysen; Yingyao Chen; Ana Paula Beck Da Silva Etges; Guvenc Kockaya; Iñaki Gutierrez-Ibarluzea; Ahmed Mohammed Seyam; Deirdre Mullen; Hans-Peter Dauben
errShare
errSave
A strategic framework for synergizing managed entry agreement efforts to access pharmaceutical products in Saudi Arabia-results from a multi-stakeholder workshop
errJOURNAL OF MEDICAL ECONOMICS
IF3
err2025-05-21
err0
errOAAI
errHussain Abdulrahman Al-Omar; Asma Abdulaziz Almuhsin; Lolwa Hamad Almudaiyan; Amal Hassan Al-Najjar; Laila Carolina Abu Esba; Hind Almodaimegh; Esraa S. Altawil; Consuela Cheriece Yousef; Mansoor Ahmed Khan; Khalid AlYahya; Jehan Alamre; Fatma Maraiki; Jaime Espín; Rosanna Tarricone; Panos Kanavos
errShare
errSave
Towards a sustainable rare disease and orphan drug ecosystem in Saudi Arabia: policy insights from a multi-stakeholder workshop
errFRONTIERS IN PHARMACOLOGY
IF4.8
err2025-05-01
err0
errOAAI
errAbozaid, Ghada Mohammed; Al-Omar, Hussain Abdulrahman; Alrabiah, Abdulaziz; Almuaither, Asma; Mcknight, Amy Jayne
errShare
errSave
A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities
errSAUDI PHARMACEUTICAL JOURNAL
IF3.4
err2024-11-01
err2
errOAAI
errAl-Omar, Hussain A.; Alshehri, Ali; Alqahtani, Saleh A.; Alabdulkarim, Hana; Alrumaih, Ali; Eldin, Mahmoud S.
errShare
errSave
Cost saving analysis of prediabetes intervention modalities in comparison with inaction using Markov state transition model-A multiregional case study
errJOURNAL OF DIABETES
IF3.7
err2024-04-25
err0
errOAAI
errAl-Omar, Hussain Abdulrahman; Czech, Marcin; Nam, Tran Quang; Gottwald-Hostalek, Ulrike; Vesic, Nikola; Whitehouse, James; Dawson, Maddy
errShare
errSave
Pharmacy practice in hospital settings in GCC countries: Dispensing and administration
errSAUDI PHARMACEUTICAL JOURNAL
IF3.4
err2023-03-01
err4
errOAAI
errMayet, Ahmed Y.; Khurshid, Fowad; Al-Omar, Hussain A.; Alghanem, Sarah S.; Alsultan, Mohammed S.; Al-jedai, Ahmed H.
errShare
errSave
The Impact of Obesity in Saudi Arabia: Healthcare Resource Use and Costs Associated with Obesity-Related Complications
errADVANCES IN THERAPY
IF4
err2023-01-21
err9
errOAAI
errAl-Omar, Hussain A.; Alshehri, Ali; Abanumay, Abdulmohsen; Alabdulkarim, Hana; Alrumaih, Ali; Eldin, Mahmoud S.; Alqahtani, Saleh A.
errShare
errSave
Obesity Burden and Impact of Weight Loss in Saudi Arabia: A Modelling Study
errADVANCES IN THERAPY
IF4
err2023-01-12
err15
errOAAI
errAlqahtani, Saleh A.; Al-Omar, Hussain A.; Alshehri, Ali; Abanumay, Abdulmohsen; Alabdulkarim, Hana; Alrumaih, Ali; Eldin, Mahmoud S.; Schnecke, Volker
errShare
errSave
Pharmacy practice in hospital settings in GCC countries: Prescribing and transcribing
errSAUDI PHARMACEUTICAL JOURNAL
IF3.4
err2021-09-01
err1
errOAAI
errAl-Jedai, Ahmed H.; Khurshid, Fowad; Mayet, Ahmed Y.; Al-Omar, Hussain A.; Alghanem, Sarah S.; Alsultan, Mohammed S.
errShare
errSave
Value drivers for pharmaceutical products in health technology assessment (HTA) in Saudi Arabia: Results from a capacity Building, Multi-Stakeholder workshop
errSAUDI PHARMACEUTICAL JOURNAL
IF3.4
err2021-09-01
err5
errOAAI
errAl-Omar, Hussain A.; Aljuffali, Ibrahim A.; Sola-Morales, Oriol
errShare
errSave
Exploring Physicians' Views, Perceptions and Experiences about Broad-Spectrum Antimicrobial Prescribing in a Tertiary Care Hospital Riyadh, Saudi Arabia: A Qualitative Approach
errANTIBIOTICS-BASEL
IF4.6
err2021-03-31
err4
errOAAI
errAlsaleh, Nada A.; Al-Omar, Hussain A.; Mayet, Ahmed Y.; Mullen, Alexander B.
errShare
errSave
Evaluating the appropriateness of carbapenem and piperacillin-tazobactam prescribing in a tertiary care hospital in Saudi Arabia
errSAUDI PHARMACEUTICAL JOURNAL
IF3.4
err2020-11-01
err9
errOAAI
errAlsaleh, Nada A.; Al-Omar, Hussain A.; Mayet, Ahmed Y.; Mullen, Alexander B.
errShare
errSave
Pharmaceutical companies views on a health technology assessment (HTA) entity in Saudi Arabia
errSAUDI PHARMACEUTICAL JOURNAL
IF3.4
err2020-06-01
err11
errOAAI
errAl-Omar, Hussain Abdulrahman; Attuwaijri, Abdulaziz Abdulhadi; Aljuffali, Ibrahim Abdulrahman
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
A
Arun J. Sanyal
H-index: 166 · Papers: 1.4K
V
Vincent Wai‐Sun Wong
H-index: 142 · Papers: 1.2K
Z
Zobair M. Younossi
H-index: 140 · Papers: 1.5K
A
Azeem Majeed
H-index: 129 · Papers: 1.2K
F
Frank Tacke
H-index: 124 · Papers: 1.4K
View more